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Fungi can cause severe invasive infections especially in the immunocompromised host. Patient populations at risk are increasing
due to ongoing developments in cancer treatment and transplantation medicine. Only limited diagnostic tools and few antifungals
are available, rendering a signiﬁcant number of invasive fungal infections life threatening. To reduce mortality rates, a better
understanding of the infection processes is urgently required. Bioluminescence imaging (BLI) is a powerful tool for such purposes,
since it allows visualisation of temporal and spatial progression of infections in real time. BLI has been successfully used to
monitor infections caused by various microorganisms, in particular bacteria. However, ﬁrst studies have also been performed
on the fungi Candida albicans and Aspergillus fumigatus. Although BLI was, in principle, suitable to study the infection process,
some limitations remained. Here, diﬀerent luciferase systems are introduced, and current approaches are summarised. Finally,
suggestions for further improvements of BLI to monitor fungal infections are provided.
1.Introduction
Bioluminescence imaging (BLI) is a noninvasive technique
that can be used to track microorganisms in living animals.
To use this technique cells are generated that emit light
from enzyme-catalysed oxidation reactions. Light emission
is detected by highly sensitive charged coupled device (CCD)
cameras that allow the collection of single photons [1].
The light-generating enzymes are generally called luciferases,
although several diﬀerent luciferases from a wide variety of
organisms and without structural relatedness are known [2].
Nevertheless, all characterised luciferases have in common
that they need oxygen for the light-emitting reaction but use
diﬀerent substrates and cofactors and emit light at diﬀerent
wavelengths. A short summary of key features of some
frequently used luciferases that will be described in more
detail is shown in Table 1.
BLIhasbeenusedtomonitorgeneexpressionanddisease
progression caused by pathogenic bacteria [3]. Furthermore,
the system has also been applied to monitor growth of
implanted tumour cells for investigating the eﬀectiveness
of therapeutic approaches [4, 5]. In terms of eukaryotic
microorganisms such as fungi, bioluminescence imaging has
mainly been used for highly sensitive monitoring of gene
expression [6, 7], whereas infection studies on fungi are
basically limited to the dimorphic yeast Candida albicans
[8, 9] and the ﬁlamentous ascomycete Aspergillus fumigatus
[10, 11]. These investigations have shown that BLI can be
used as a powerful tool to study the infection process, but a
ﬁne-tuningofthesystemisrequiredtoincreaseitssuitability.
Thus, this paper summarises the key features of diﬀerent
luciferase systems, reports on the results obtained for fungal
infections, and provides suggestions for future applications
and improvements.
2. BacterialLuciferases
For the generation of bioluminescent bacteria generally a
lux operon from a prokaryotic origin [12] is used. This
operonnotonlyharboursgenescodingfortheheterodimeric
luciferase (luxA and B) with a native mass of approximately
77kDa [13] but also genes required for the production of
the luciferase substrate (luxC, D, E). The latter genes are2 International Journal of Microbiology
Table 1: Key features of selected luciferases from diﬀerent phylogenetic origins.
Luciferase origin Organism (family) Substrate Cosubstrate Composition
(mass)
Localisation
(native)
Peak emission
(nm)
Vibrio spec. Bacteria
(Vibrionaceae)
Long-chain aliphatic
aldehyde O2;F M N H 2
heterodimer
(77kDa) Cytoplasm 490
Photorhabdus spec. Bacteria
(Enterobacteriaceae)
Long-chain aliphatic
aldehyde O2;F M N H 2
heterodimer
(77kDa) Cytoplasm 490
Photinus pyralis Fireﬂy
(Lampyridae) Benzothiazoyl-thiazole O2;A T P monomer
(62kDa) Peroxisome 561–578∗
Pyrophorus
plagiophthalamus
Click beetle
(Elateridae) Benzothiazoyl-thiazole O2;A T P monomer
(62kDa) Peroxisome 548–594
Renilla reniformis Sea pansy
(Renillidae)
Benzylimidazo-pyrazinone
coelenterazine O2
monomer
(35kDa) Cytoplasm 480
Gaussia princeps Copepod
(Metridinidae)
Benzylimidazo-pyrazinone
coelenterazine O2
monomer
(19kDa) Secreted 480
∗Peak emission is temperature sensitive and gradually shifts to 612nm at 37◦C[ 22].
responsible for production of a long-chain aldehyde that
is oxidised together with a reduced riboﬂavin phosphate
(FMNH2) for the light-generating reaction [14]. To enable
a heterologous expression of the lux operon in various bacte-
ria, several optimisation strategies have been applied involv-
ing the use of diﬀerent promoters and codon adaptations
as required by the respective host [15]. Such adaptations
allowed studying the infection process of several bacteria
such as Salmonella typhimurium, Listeria monocytogenes,
Bacillus anthracis, Mycobacterium tuberculosis, and others
[3, 16–19].
Besides using the lux operon for virulence studies, it is
also used as a reporter system to study promoter activity
in bacteria under various environmental conditions. Here,
although the reporter system is functional when all genes are
located in a single operon, some substrate limitations can
occur that limit the linearity of the reporter system. Recent
studies have shown that this limitation is circumvented by
independent and constitutive expression of the substrate-
producing genes luxC, D, E and by only controlling expres-
sion of the luciferase-encoding genes by the promoter of
interest [20].
Attempts have also been made to use the bacterial system
for expression in eukaryotes since the bacterial lux operon
provides the only system for which the genes for substrate
synthesis are known. This allows the production of auto-
bioluminescent cells without the need for external addition
of luciferase substrates. However, since eukaryotes need a
promoter controlling the expression of each single gene and,
additionally, require a codon adaptation of the lux genes,
studies using lux genes in eukaryotes are rather limited.
Recently, it was possible to transfect mammalian HEK293
cells with a lux cassette harbouring codon-optimised genes
linked by internal ribosomal entry sites to limit the number
of promoter elements due to bicistronic gene expressions
[21]. By this method it was possible to detect a minimum of
20,000 HEK cells in vitro. Additionally, after subcutaneous
injection it was possible to redetect these lux cassette-ex-
pressing cells from living mice [21]. However, although
this system allows the continuous long-term observation of
a cell population without the need for external substrate
addition,thesystemstillpossessesseveraldrawbacks.Despite
the constitutive expression of a ﬂavin reductase gene,
the amount of reduced FMNH2 appeared limited in the
eukaryotic system since the addition of FMNH2 to the
culture medium strongly increased luminescence signal
intensity. Thus, although the substrate for luciferase can be
autonomously produced by the cell, one of the essential
cosubstrates remains limited. Furthermore, the use of these
expression cassettes in other eukaryotes such as fungi will
need species-speciﬁc adaptations involving time-consuming
cloning procedures. Additionally it should be noted that,
despite synthetic optimisation of lux genes for increased
expression and production rates in HEK cells, luminescence
signal intensity appeared rather low. Thus, combined with
the short wave length of light emission (peak emission at
490nm), this system may have limitations in monitoring cell
proliferation from deeper tissues.
3. Beetle Luciferases
Studies usingluciferasesinresearchoneukaryotesfrequently
useenzymesthatderivefromluminousbeetles(Lampyridae)
or click beetles (Elateridae). The most prominent examples
are the ﬁreﬂy luciferase from Photinus pyralis and the
luciferase from the click beetle Pyrophorus plagiophtalamus
[23]. Luciferases from these beetles are monomeric enzymes
with a molecular mass of approximately 62kDa and a
protein sequence identity of around 50%. Additionally, the
native protein sequences from both species display a C-
terminal peroxisomal import sequence (SKL) for targeting
to specialised peroxisomes of photocytes in the beetle
lantern organ. Due to this targeting sequence, luciferases
are also transported to peroxisomes of other eukaryotes
as shown for mammalian cells, yeast, and plants [24, 25].
Although ﬁreﬂies and click beetles are only distantly related,
luciferases from both families use the same substrate, which
is a heterocyclic water soluble acid (benzothiazoyl-thiazole)
generally called luciferin. Luciferin is oxidised in an ATP-
dependent manner leading to oxyluciferin, AMP, CO2,a n dInternational Journal of Microbiology 3
light. The quantum yield of this reaction was determined as
0.88, which is the highest yield for any luciferase-catalysed
reaction characterised so far [23]. Click beetle luciferases
diﬀer in the wavelength of emitted light ranging from green
(548nm) to orange (594nm), and this range has been ob-
served from individual beetles implying that diﬀerent lucif-
erases may be produced within the same insect [26]. In con-
trast, the ﬁreﬂy P. pyralis only produces a single luciferase
with a peak intensity of light emission at 561–578nm [22,
23]. However, it should be noted that a spectral shift to
>610nm (612–617nm) occurs at pH below 7.5, tempera-
tures above 35◦C, addition of denaturants or several heavy
metals [22, 27]. Thus, it has been shown that light produced
by a ﬁreﬂy luciferase within a mammalian system (body
temperature ≈37◦C) is red shifted [22]. Although this shift
is accompanied by a reduced quantum yield [23], it is
compensated by an increase in luciferase activity [22] and,
thus, allows a better detection of microorganisms from deep
tissues due to reduced light absorption from haemoglobin
[28].
Genes for synthesis of luciferin are still unknown, and
the external addition of this luciferase substrate is required
to obtain bioluminescent signals. To investigate whether
this requirement for luciferin supplementation limits the
suitability of the system in vivo, the distribution of luciferin
wasstudiedinamurinesystem.Inaqualitativeanalysisitwas
shown that 20min after intraperitoneal injection luciferin
was detectable in tissue homogenates from brain, skin, and
liver. Furthermore, the repeated injection of 126mg/kg of
l u c i f e r i na p p e a r e dt oh a v en oa d v e r s et o x i ce ﬀect on animals
[29]. However, quantitative analyses using either radioiodine
labelled [30]o r14C-labelled luciferin [31] showed that dis-
tribution velocity and tissue accumulation vary depending
on the route of luciferin application (intravenous versus
intraperitoneal) and time of measurement after application.
Both studies independently showed that luciferin availability
especially in brain, muscles, and bones remains at low rates
regardless of the application route and may, thus, act as a
limiting factor for luciferase activity detection. Nevertheless,
although substrate concentrations may be too low to allow
substrate saturation for the light-emitting reaction, at least a
qualitative assessment of bioluminescence can be envisaged
from all targeted organs. Thus, although the number of
injections and amount of luciferin applied to individual
animals should be kept to a minimum, tracking of an
infection at various time points and from diﬀerent body sites
should be possible despite the uneven substrate distribution
in living animals.
As mentioned above, beetle luciferases require ATP for
substrateoxidation,andthisfeaturecanbeusedtodetermine
minute amounts of ATP released from cell lysates [32]. How-
ever, this feature of beetle luciferases may also act as a draw-
back during in vivo measurements. Due to the ATP depen-
dence of these luciferases, not only the substrate luciferin
may be limited, but also the ATP concentration, which is
dependent on the physiological state of the cell. Thus, co-
substrate requirements, ATP in the beetle luciferase, and
FMNH2 in the bacterial lux system are major disadvantages
of these bioluminescence-based reporter systems.
4. Coelenterazine-Dependent Luciferases:
RlucandGluc
Another type of luciferases frequently used as a reporter
in eukaryotic cells oxidises the substrate benzylimidazo-
pyrazinone coelenterazine (short coelenterazine) indepen-
dent of ATP or FMNH2. Thus, these luciferases do not
require a special physiological state of the host cell (despite
the presence of oxygen) to act as a reporter and can be mea-
sured in cell-free extracts by coelenterazine addition. Two
coelenterazine-dependent luciferases with diﬀerent char-
acteristicsaremainlyusedasreporters:(i)theluciferasefrom
the sea pansy Renilla reniformis (Rluc) and (ii) from the
copepod Gaussia princeps (Gluc).
Renilla luciferase has been puriﬁed to homogeneity and
biochemically characterized approximately 35 years ago. The
enzyme is a monomer of 35kDa that emits light at 480nm.
Although it is rather stable at elevated temperatures, it tends
to irreversibly form inactive dimers and multimers when
stored at concentrations exceeding 0.5mg/mL [33]. Com-
paredtothequantumyieldofﬁreﬂyluciferases,thequantum
yield of Rluc with coelenterazine is approximately 10 times
lower with only about 6-7%. Furthermore, also the substrate
turnover rate appears rather low [33], which is a drawback
in terms of sensitivity of the system. In addition, although
the light emission at 480nm is ideally suited to excite the R.
reniformis green ﬂuorescent protein, light at this wavelength
is strongly absorbed by haemoglobin. Nevertheless, since
bioluminescence background signals from animals are gen-
erally very low, Rluc has been successfully used to generate
reporter cells for in vivo monitoring of cancer development
in murine systems [34–36]. However, it has been reported
that the multidrug resistance MDR1 P-glycoprotein (Pgp)
eﬃciently removes coelenterazine from the cell and may,
thus, lead to an underestimation of bioluminescence by the
Rluc system [37]. In contrast, such a substrate export has
not been described for the luciferin of ﬁreﬂy luciferase. It
has also been shown that the distribution of coelenterazine
is strongly dependent on the route of application. Studies
on Rluc-expressing Trypanosoma brucei cells showed that
the parasites were detected at diﬀerent body sites depending
on coelenterazine injection either via the intravenous or the
intraperitoneal route [38]. Thus, although ﬁreﬂy luciferin
is also not evenly distributed between diﬀerent body sites
bioavailability appears superior compared to coelenterazine.
In addition, coelenterazine tends to autooxidation in the
presence of serum albumin which enhances background sig-
nals, a phenomenon that is not observed with ﬁreﬂy luciferin
[39].
The luciferase from Gaussia princeps has several diﬀerent
features compared to Rluc. Gluc is naturally secreted [40]
and assumed to keep predators’ attention while the copepod
escapes. The secretion signal of this luciferase is also active in
other eukaryotic cells as exempliﬁed by expression studies in
CHO and HepG2 cells [41]. Although, as described for Rluc,
native Gluc consists of a monomeric structure, its molecular
mass of 19kDa is signiﬁcantly smaller than that of Rluc
[42]. Furthermore, although coelenterazine is also used as a
substrate and light at a wavelength of 480nm is emitted in4 International Journal of Microbiology
an ATP-independent manner, light intensity is much higher
than that of Rluc [43]. The enzyme additionally possesses a
very high thermostability retaining more than 50% activity
after 30min incubation at 95◦C[ 44].
The secretion of Gluc has several advantages that may
also turn into disadvantages of the system. Due to its
high stability, Gluc can be easily identiﬁed from culture
supernatants, thus enabling to detect intracellular events
from the environment [43]. Additionally, the extracellular
localisation of Gluc provides an easier access to the substrate
coelenterazine that can be limited in Pgp-positive cells by
using the intracellular Rluc system. However, the secretion
of Gluc also leads to an uncontrolled distribution of Gluc
via the blood stream causing elevated background levels and
less distinct signals at the site where luciferase-producing
cells are located. To minimise the drawbacks of secretion
attemptshavebeenmadetoproducemembrane-boundGluc
by fusing the enzyme with the CD8 transmembrane domain
and expressing the construct in T cells. This procedure
resulted in increased signal intensities of transfected cells
and allowed in vivo monitoring of T-cell recruitment to
implanted cancer cells [45]. Thus, future experiments may
favour speciﬁc Gluc versions rather than Rluc for in vivo
imaging.
5.L uc if e rasesasR e po rt e rS yst e m sinF ungi
First successful approaches to produce ﬁreﬂy luciferase in
the yeast Saccharomyces cerevisiae were published in 1988
[46]. The native cDNA was cloned under control of the
alcohol dehydrogenase promoter and allowed a maximum
luciferaseyieldof10ng/mLofculture.However,thisamount
was assumed to be too low for use as a suitable in vivo
reporter. Thus, diﬀerent promoters were selected to increase
luciferase production rates. Accompanied with optimised
culture and assay conditions it was possible to detect
luciferase activity from a minimum of 1 × 106 intact
yeast cells [47]. However, this sensitivity still appeared too
low for using the ﬁreﬂy luciferase system as a suitable
reporter for gene expression analyses from intact cells. A
search for the problems causing this low sensitivity led to
the speculation that the peroxisomal localisation of native
ﬁreﬂy luciferase mediated by the C-terminal SKL sequence
might limit the availability of substrates and thus causing
low light emission. Indeed, removal of the peroxisomal-
targeting sequence enhanced light emission of transformed
cells by two to three orders of magnitude. In addition,
growth speed of cells harbouring the modiﬁed luciferase
gene was signiﬁcantly enhanced compared to cells expressing
the native gene sequence, indicating that the peroxisomal
localisation aﬀected the natural physiology of yeast cells [6].
Subsequently, luciferase assay systems were developed for
yeast cells that expressed both, ﬁreﬂy and Renilla luciferase at
the same time allowing two study two independent cellular
responses by BLI [48, 49].
Similar to S. cerevisiae, ﬁrst approaches to use the ﬁreﬂy
luciferase as a reporter in the dimorphic yeast Candida
albicans were only partially successful [50]. Expressions of
the ﬁreﬂy luciferase under control of the phase-speciﬁc
WH11 promoter yielded no detectable bioluminescence.
However, this negative result was attributed to the presence
of several leucine residues encoded by CUG triplets, which
are translated into serine in C. albicans and might have
led to a nonfunctional protein [51, 52]. Thus, to generate
a bioluminescent reporter system suitable to study gene
expression in C. albicans the Renilla luciferase was used,
because its gene does not contain in frame CUG codons.
Indeed, use of Rluc led to well-detectable bioluminescence
and was suitable to study gene expression of various genes
in both cell-free extracts and intact cells [51]. Subsequently,
the Rluc system was also used to investigate the eﬀectiveness
of a tetracycline-regulated expression system in C. albicans
[53]. Later, the ﬁreﬂy luciferase was revisited. By exchanging
all CUG codons from a vector carrying the ﬁreﬂy luciferase
gene designed for expression in mammalian cells it was
possible to generate bioluminescent C. albicans cells. This
ﬁreﬂy luciferase system was suitable for use as a selection
marker in the transformation of clinical wild-type isolates
without the need for other growth-disturbing markers that
could aﬀect cellular physiology [54]. However, although this
system worked well for in vitro analyses, the system displayed
some problems in infection studies as will be outlined below.
Bioluminescent reporters have also been generated for
useinﬁlamentousfungi.Inatrialforstudyingtheexpression
of a xylanase gene from Aspergillus oryzae in the close relative
Aspergillus nidulans a luciferase reporter system was used.
Unfortunately,nodetailsonthesourceofluciferasehadbeen
provided,anditcanonlybespeculatedthataﬁreﬂyluciferase
was used. However, the observed bioluminescence correlated
withtheexpectedexpressionpatternofthexylanasegeneand
indicated that BLI should be functional also in ﬁlamentous
fungi [55]. Subsequently, BLI was discovered for investigat-
ing circadian rhythms in the ascomycete Neurospora crassa
by using a ﬁreﬂy luciferase gene with improved codons for
expression in mammalian cells [56]. However, initial studies
revealed that light emission from intact cells was rather low
and eﬀorts were made to increase signal intensity. Thus,
a fully codon-optimised synthetic version of the luciferase
gene was constructed that emitted high bioluminescence
signals when fungal transformants were grown on media
supplemented with luciferin. By this method it was possible
to follow the circadian expression of clock-controlled genes
over several days [7].
In summary, although studies using luciferase systems
in fungi are still rather limited, this technique seems to
provide a powerful tool to study gene expression from intact
cells. Additionally, the use of dual reporter systems, such
as a combination of Rluc and ﬁreﬂy luciferase, allows the
independent monitoring of gene expression by BLI, because
both luciferases are highly speciﬁc for their respective
substrate.
6.Bioluminescence ImaginginFungal
Virulence: Candida albicans
Investigations using BLI for monitoring fungal infections
in vivo are basically limited to C. albicans and Aspergillus
fumigatus. Despite the small number of investigations,International Journal of Microbiology 5
the detailed investigations on system limitations may help
to design reporter systems that could improve the BLI
technique also for other fungi.
As mentioned above, Doyle et al. constructed a ﬁreﬂy
luciferase for use in C. albicans in which all CUG codons of
a luciferase gene adapted for expression in mammalian cells
werereplacedbyCUUcodons allowingcorrecttranslationof
the gene into a functional protein [54]. This system was, in
principle, suitable to follow the induction of gene expression
as shown by the induced expression of the hyphal-speciﬁc
gene HWP1 under hyphae-inducing conditions. However,
when light emission was studied from constitutively active
promoters, it was noted that bioluminescence was signif-
icantly lower in hyphae than in yeast cells although cell-
free extracts from both cell types revealed similar biolu-
minescence levels. Thus, it was concluded that the uptake
of luciferin might be hampered by the reorganised cell
wall in C. albicans hyphae [54]. However, the same group
also investigated the suitability of the system for studying
pathogenesis in mice by BLI [8]. In a vulvo-vaginal infection
model the system was suitable to visualise the persistence
of C. albicans within the vaginal lumen. To allow substrate
saturation in these experiments luciferin was directly applied
to the vaginal lumen and light emission correlated with
the number of C. albicans cells. Furthermore, in vulvo-
vaginal infected mice a topical treatment with miconazole
revealed clearance of the infection as visualised by BLI.
However, imaging of systemic candidiasis was hampered
by bioluminescence intensities that were too dim to follow
pathogenesis, and this was attributed to the formation of
hyphae during tissue penetration of C. albicans cells.
Although the explanations provided by the author refer-
ring to a limited substrate uptake by hyphae sound valid,
other reasons could also explain why monitoring of systemic
infections failed. First, a much stronger bioluminescence
is required when studying infections from deep tissues
comparedtomoresuperﬁcialinfections.Thisisduetostrong
light absorption from haemoglobin, and, as a general rule, it
can be assumed that light emission intensity is reduced by
a factor of 10 by each cm of tissue depth [16]. Although
the ﬁreﬂy luciferase gene was codon adapted in terms of
the in frame CUG codons, an inspection of the codon
adaptation index (CAI) against highly expressed C. albicans
genes by using the dCAIoptimizer reveals a CAI of only
27%. Thus, translation of the luciferase-coding RNA might
have been limited by a shortage of the respective tRNAs.
Synthesis of a fully codon-adapted luciferase gene might,
therefore, signiﬁcantly increase protein production rates and
the accompanied bioluminescence signal intensity.
Another limitation of the gene sequence utilised could
have derived from the peroxisomal-targeting sequence of the
luciferase used for constructing the bioluminescent C. albi-
cans cells. As outlined above, studies on S. cerevisiae showed
that light emission is strongly reduced when luciferase
is targeted to yeast peroxisomes [6]. Thus, not only the
structure of the cell wall, but also the amount of peroxisomes
and the available ATP content within these compartments
m a yv a r yi nC. albicans hyphae and may limit substrate
availability for the luciferase reaction. Thus, the simple
removal of the peroxisomal-targeting sequence might have
enhanced the suitability of the system for studying systemic
infections. At the moment, studies are under way to conﬁrm
both hypotheses.
However, due to the described limitations of studying
systemic C. albicans infection by use of the ﬁreﬂy luciferase,
Enjalbert et al. investigated the suitability of a Gaussia lu-
ciferase for monitoring C. albicans infections [9]. Since
Gluc is naturally secreted, it was assumed that cellular
barriers would not hamper substrate availability. However,
to avoid a systemic distribution of Gluc, the gene was fused
with the sequence coding for the glycophosphoinositol-
linked cell wall protein PGA59. This strategy was similar
to that described for trapping Gluc on the surface of T
cells [45]. C. albicans cells producing the cell-wall-anchored
Gluc were compared to C. albicans cells expressing Rluc,
and the highly superior luminescence intensity of the Gluc
system was conﬁrmed. Light emission was in a range that
allowed visualisation from intact cells even by the na-
ked eye. Additionally, it was shown that, when using as
constitutive expression system, no signiﬁcant diﬀerences
were observed between yeast cells and hyphae [9]. This
system was suitable to study the progression of infection
after subcutaneous, cutaneous, and vaginal infections. In
cutaneous infections, coelenterazine was directly added to
the abraded skin area, whereas in subcutaneous infections
coelenterazine was supplied subcutaneously and in vaginal
infections by applying the substrate to the vaginal lumen. By
these methods it was ensured that coelenterazine reached the
site of infection in suﬃcient amounts and light intensities
correlated well with the fungal burden.
When the cell-wall-bound Gluc system was used to
study progression of systemic infections, no satisfying results
were obtained. Under in vivo conditions the detected lu-
minescence intensities did not exceed background levels
although homogenized kidneys incubated with coelenter-
azine revealed luminescence signals [9]. Several reasons may
account for this failure to monitor systemic infections. One
major problem, as discussed by the authors, might have
derived from the limited distribution of coelenterazine after
intraperitoneal injection. This seems reasonable, since a sim-
ilar observation was made for experiments performed with
T. brucei in which intraperitoneal or intravenous injection
of coelenterazine revealed diﬀerent results for the locali-
sation of parasites [38]. However, only the intraperitoneal
coelenterazine injection had been utilised to study systemic
C. albicans infections, and it cannot be excluded that an
intravenous substrate injection might have been able to
track the infection. However, in terms of investigating the
dissemination to yet unknown body sites, the problems of
substrate availability cannot be neglected. Another problem
might have been derived from the light emission wavelength
of the selected luciferase. Gluc emits light at a peak wave-
length of 480nm with no emission above 600nm [43]. Since
haemoglobin and tissue absorbance of light are much less
pronounced at wavelengths above 600nm [1], the strong
absorption at 480nm accompanied by an autooxidation
of coelenterazine might have hampered the detection of
C. albicans from deep tissues. Thus, coelenterazine-based6 International Journal of Microbiology
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Figure 1: Bioluminescence imaging of invasive aspergillosis. The
depicted mouse was immunosuppressed with cortisone acetate
and infected intranasally with the bioluminescent A. fumigatus
strain C3. Bioluminescence was acquired 28h after infection.
Light emission is detected from both lung lobes indicating the
establishment of bronchopulmonary aspergillosis. (Figure kindly
provided by O. Ibrahim-Granet).
systems might only become suitable reporters for systemic
C. albicans infections when substrates are developed that
allow enhanced tissue distributions and a red shift of light
emission.
7.Bioluminescence ImaginginFungal
Virulence: Aspergillus fumigatus
BLI has also been investigated for its suitability to monitor
progression of A. fumigatus infections from living mice.
For this purpose, the ﬁreﬂy luciferase codon optimised for
expression in mammalian cells but without a peroxisomal-
targeting sequence had been used [10]. To obtain strains
with a constitutive luciferase production expression of the
ﬁreﬂy luciferase was controlled by the glyceraldehyde-3-
phosphate dehydrogenase promoter. Indeed, light emission
was easily detectable from intact cells by either using a
microplate readeror other bioluminescence imaging devices.
Since A. fumigatus is a ﬁlamentous fungus, this observation
indicates that the cell wall of hyphae does not necessarily
cause problems for intracellular luciferin availability. The
system was also suitable to study the antimycotic eﬃciency
of several drugs under in vitro conditions.
When tested in a murine model for invasive bronchopul-
monary aspergillosis (IBPA) by infecting mice immuno-
compromised by cortisone acetate, strong bioluminescence
signals were obtained from the infected lung already 24h
after infection (Figure 1). Thus, this model provides the ﬁrst
example in which a deep tissue infection of a fungus was
successfully monitored by BLI [10]. However, signal inten-
sities strongly declined at later days, and histopathologic
analyses showed a severe inﬁltration of immune eﬀector cells
consistingofmainlyneutrophilsthatattackedfungalhyphae.
Although subsequent analyses by qPCR showed that indeed
the amount of living fungal cells did not increase three days
afterinfectioncomparedtoa24htimepoint [11]the decline
of the bioluminescence signal was surprising. Additionally,
when an antibody-mediated neutrophil depletion strategy
was used to render mice susceptible for IBPA, luminescence
signals remained rather low and histopathology revealed a
rapid and severe inﬁltration of monocytes to the site of
infection.
To explain this phenomenon of decreasing luminescence
signal intensity, it needs to be mentioned that all luciferases
require dissolved oxygen for the oxidation of the respective
substrate. Thus, it was speculated that the severe inﬂam-
matory process might cause anaerobic niches within the
lung tissue [10]. In addition, within necrotic tissues the
distribution of luciferin from the intraperitoneal site may be
lowcausingsubstratelimitationatthesiteofinfection.These
speculations were supported by the fact that lungs removed
at necropsy and injected with oxygen-saturated luciferin
revealed luminescence signal intensities that correlated well
with the expected fungal burden [10, 11].
The limitations of fungal quantiﬁcation were less pro-
nounced when mice were rendered leukopenic by using the
cytostatic drug cyclophosphamide [11]. Under this regimen
the amount of fungal biomass is heavily increasing, and no
immune eﬀector cells can be recruited to attack hyphae.
Quantiﬁcation of the bioluminescence signals showed that
under this immunosuppression regimen signal intensity
steadily increased until mice succumbed to infection. Thus,
the ﬁreﬂy luciferase system, in principle, appears suitable to
study the temporal and spatial progression of infection.
Preliminary analyses have also shown that the biolumi-
nescent A. fumigatus strain seems suitable to monitor pro-
gression of disseminated disease and signals were easily
detected from all infected organs (unpublished results).
However, to increase the sensitivity of the system, we
are currently constructing and testing diﬀerent Aspergillus
species that carry a synthetic ﬁreﬂy luciferase gene adapted
totheA.fumigatuscodonusage(Figure 2).Itisexpectedthat
the sensitivity from this construct will increase by at least a
factor of 10. This increase would be suﬃcient to track even
minute amounts of hyphae from infected tissues and should
allow following the eﬃciency of antifungal therapy under in
vivo conditions.
8. Conclusion
Diﬀerent luciferase systems have been established for use in
infection studies. The bacterial lux operon seems well appli-
cable for studying bacterial infection, but appears less suit-
able for use in eukaryotic cells. Here, mainly coelenterazine-
dependent and beetle luciferases are used, but both systems
have limitations.International Journal of Microbiology 7
A. fumigatus
WT
A. fumigatus
C3
A. fumigatus
2/7/1
Figure 2:VisualisationofbioluminescencefromA.fumigatuscolonies.TheA.fumigatuswild-typestrainCBS144.89andthebioluminescent
strains C3 and 2/7/1 are shown. Strains were grown for 48h in the presence of 1mM D-luciferin on glucose minimal medium. The upper
lane shows a daylight photograph, the bottom line bioluminescence images of the colonies acquired by a medium sensitive Versa Doc
luminescence imaging system. Strain C3 carries four ectopic integrations of the P. pyralis luciferase gene codon adapted for expression in
mammalian cells. Only a moderate light emission is detected. Strain 2/7/1 carries two integrations of the P. pyralis gene codon optimised for
expression in A. fumigatus. Light emission is strongly enhanced.
To overcome all problems the optimal bioluminescence
reporter system should fulﬁl the following characteristics:
(i) high expression rates, (ii) strong signal intensity with
high quantum yield of the reaction, (iii) able to track
deep infections with light emission far above 600nm, (iv)
independent from the host response (oxygen independent),
(v) produce its own substrate intracellular, and (vi) should
not aﬀect physiology of the cell.
Unfortunately, at the moment such an optimal reporter
system does not exist. Thus, the best suited system needs
to be selected in regard to the scientiﬁc question. While
superﬁcial infections may be studied by coelenterazine-
dependent luciferases, the limited substrate distribution
and the short wavelength do not favour its selection for
systemic infections. However, especially for gene expression
studies in culture media, the Gluc system seems to provide
an excellent candidate. Furthermore, besides coelenterazine
and dissolved oxygen these luciferases are independent
of additional cofactors that need to be provided by the
host cell. Beetle luciferases are much larger proteins (three
times the size of Gluc) and have been shown, under some
circumstances, to aﬀect fungal growth rate. Furthermore,
they require cellular ATP as an essential cofactor that needs
to be used from the cellular pool. However, light emission of
these luciferases is above 600nm under in vivo conditions,
and luciferin distribution appears more homogenous. Thus,
ﬁreﬂy luciferases may provide a better suited system for in
vivo monitoring of fungal infections. Nevertheless, subcellu-
lar localisation and codon adaptations may play important
roles for successfully applying this system to research.
In the future, investigations using BLI with other fungal
pathogens will be performed. These studies will help to
optimise luciferase reporter systems and will contribute to
the understanding of pathogenicity mechanisms. A special
f e a t u r ew i l ld e r i v ef r o mt h ein vivo monitoring of the
eﬃciency of antifungals in individual animals. Thereby, BLI
will not only reduce the required number of animals but also
allow identifying optimised treatment strategies to combat
life-threatening fungal infections.
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